What is Scienture Holdings, Inc's earnings per share (EPS)?

Scienture Holdings, Inc (SCNX) reported diluted earnings per share of $-2.70 for fiscal year 2025. This represents a -208.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Scienture Holdings, Inc Financials

SCNX

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Scienture Holdings, Inc (SCNX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SCNX FY2025 2026-04-30

External financing, not customer revenue, is the visible engine keeping this pre-commercial balance sheet functioning.

In FY2025, operating cash burn was $13.4M against just $432K of revenue, underscoring how little of the cost structure is supported by customers. At the same time, a financing inflow of $19.7M reversed the prior year's sub-1.0x current ratio, showing liquidity improved because capital arrived from outside the business, not because operations became self-funding.

The jump in gross margin to 76.8% from 4.4% looks dramatic, but it comes off a very small revenue base. Gross profit was only $331K while SG&A alone was $7.9M, so higher markup did not translate into an operating model that can carry its overhead, and R&D added another fixed layer.

The net loss of $41.5M was far larger than the operating cash burn of $13.4M, so reported losses were much harsher than the year's actual cash drain. With $6.7M of year-end cash, funding capacity still depends more on access to capital than on customer receipts.

Financial Health Signals

Financial Profile 26/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Scienture Holdings, Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Scienture Holdings, Inc has an operating margin of -9867.9%, meaning the company retains $-9868 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -10758.7% the prior year.

Growth

Scienture Holdings, Inc's revenue surged 215.9% year-over-year to $432K, reflecting rapid business expansion. This strong growth earns a score of 0/100.

Leverage

Scienture Holdings, Inc carries a low D/E ratio of 0.20, meaning only $0.20 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 98/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Scienture Holdings, Inc's current ratio of 2.89 indicates adequate short-term liquidity, earning a score of 55/100. The company can meet its near-term obligations, though with limited headroom.

Returns

Scienture Holdings, Inc generates a -59.2% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from 11.5% the prior year.

Piotroski F-Score Neutral

5/9

Scienture Holdings, Inc passes 5 of 9 financial strength tests. 1 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality

0.32x

For every $1 of reported earnings, Scienture Holdings, Inc generates $0.32 in operating cash flow (-$13.4M OCF vs -$41.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-10.4x

Scienture Holdings, Inc earns $-10.4 in operating income for every $1 of interest expense (-$42.6M vs $4.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$432K

YoY+215.9%

5Y CAGR-52.1%

10Y CAGR-17.4%

Scienture Holdings, Inc generated $432K in revenue in fiscal year 2025. This represents an increase of 215.9% from the prior year.

EBITDA

-$42.1M

YoY-186.4%

Scienture Holdings, Inc's EBITDA was -$42.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 186.4% from the prior year.

Net Income

-$41.5M

YoY-557.9%

Scienture Holdings, Inc reported -$41.5M in net income in fiscal year 2025. This represents a decrease of 557.9% from the prior year.

EPS (Diluted)

$-2.70

YoY-208.9%

Scienture Holdings, Inc earned $-2.70 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 208.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$6.7M

YoY+2062.3%

5Y CAGR+2.4%

10Y CAGR+55.9%

Scienture Holdings, Inc held $6.7M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

41M

YoY+364.3%

Scienture Holdings, Inc had 41M shares outstanding in fiscal year 2025. This represents an increase of 364.3% from the prior year.

Margins & Returns

Gross Margin

76.8%

YoY+72.4pp

5Y CAGR+43.5pp

10Y CAGR-16.7pp

Scienture Holdings, Inc's gross margin was 76.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 72.4 percentage points from the prior year.

Operating Margin

-9867.9%

YoY+890.8pp

5Y CAGR-9853.3pp

10Y CAGR-9863.2pp

Scienture Holdings, Inc's operating margin was -9867.9% in fiscal year 2025, reflecting core business profitability. This is up 890.8 percentage points from the prior year.

Net Margin

-9618.0%

YoY-16252.7pp

5Y CAGR-9603.2pp

10Y CAGR-9579.7pp

Scienture Holdings, Inc's net profit margin was -9618.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 16252.7 percentage points from the prior year.

Return on Equity

-59.2%

YoY-70.7pp

5Y CAGR-30.0pp

10Y CAGR+359.2pp

Scienture Holdings, Inc's ROE was -59.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 70.7 percentage points from the prior year.

Capital Allocation

R&D Spending

$2.0M

YoY-12.5%

Scienture Holdings, Inc invested $2.0M in research and development in fiscal year 2025. This represents a decrease of 12.5% from the prior year.

Share Buybacks

N/A

Capital Expenditures

N/A

SCNX Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$432K+215.9%	$137K-90.0%	$1.4M-86.7%	$10.3M+3.6%	$9.9M-42.2%	$17.1M
Cost of Revenue	$100K-23.4%	$131K-90.1%	$1.3M-72.2%	$4.7M-8.0%	$5.1M-54.9%	$11.4M
Gross Profit	$331K+5420.1%	$6K-87.8%	$49K-99.1%	$5.5M+16.3%	$4.7M-16.8%	$5.7M
R&D Expenses	$2.0M-12.5%	$2.2M	N/A	N/A	N/A	N/A
SG&A Expenses	$7.9M+18.7%	$6.7M+399.6%	$1.3M-20.9%	$1.7M-10.9%	$1.9M-74.7%	$7.5M
Operating Income	-$42.6M-189.7%	-$14.7M-234.4%	-$4.4M-50.8%	-$2.9M+44.9%	-$5.3M-111.1%	-$2.5M
Interest Expense	$4.1M+205.7%	$1.3M+11.5%	$1.2M+256.4%	$336K+1325.2%	$24K-19.7%	$29K
Income Tax	-$2.0M-273.3%	-$534K	N/A	N/A	N/A	N/A
Net Income	-$41.5M-557.9%	$9.1M+150.8%	-$17.8M-413.9%	-$3.5M+34.7%	-$5.3M-109.6%	-$2.5M
EPS (Diluted)	$-2.70-208.9%	$2.48+110.6%	$-23.35-280.9%	$-6.13	$-0.65	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$56K	N/A	$590K	N/A	$10K	N/A	$65K+246.9%	$19K
Cost of Revenue	$2K	N/A	$15K	N/A	$10K	N/A	$61K+214.3%	$19K
Gross Profit	$54K	N/A	$575K	N/A	$673	N/A	$4K+652.3%	-$703
R&D Expenses	$794K	N/A	$169K-79.9%	$844K+46.8%	$575K	N/A	$1.3M	N/A
SG&A Expenses	$1.1M	N/A	$2.2M-26.0%	$2.9M+115.9%	$1.4M	N/A	$169K-59.4%	$415K
Operating Income	-$3.5M	N/A	-$4.4M+15.4%	-$5.2M-44.4%	-$3.6M	N/A	-$3.5M-133.9%	-$1.5M
Interest Expense	$37K	N/A	$1.8M+176.0%	$653K-2.6%	$671K	N/A	$217K+4293.5%	$5K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$3.4M	N/A	-$3.6M+46.3%	-$6.7M-119.3%	-$3.1M	N/A	-$3.2M-73.6%	-$1.8M
EPS (Diluted)	$-0.08	N/A	$-0.19+60.4%	$-0.48-45.5%	$-0.33	N/A	$-1.34-3.1%	$-1.30

SCNX Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$84.2M-19.7%	$104.9M+736.6%	$12.5M+237.8%	$3.7M-35.7%	$5.8M-41.1%	$9.8M
Current Assets	$7.9M+25.5%	$6.3M+129.0%	$2.8M+31.5%	$2.1M-52.1%	$4.4M-52.6%	$9.2M
Cash & Equivalents	$6.7M+2062.3%	$308K+85245.2%	$361-100.0%	$1.1M-64.9%	$3.1M-47.2%	$5.9M
Inventory	$213K	N/A	$968-98.5%	$66K+16.4%	$56K-95.5%	$1.3M
Accounts Receivable	$731K+6485.0%	$11K+30.8%	$8K-98.7%	$630K-35.7%	$979K+21.6%	$805K
Goodwill	N/A	$21.4M	N/A	$0	$0	N/A
Total Liabilities	$14.1M-45.5%	$25.8M+115.0%	$12.0M+256.1%	$3.4M+68.7%	$2.0M+79.2%	$1.1M
Current Liabilities	$2.7M-65.4%	$7.9M-31.6%	$11.6M+438.3%	$2.1M+131.8%	$926K+9.9%	$842K
Long-Term Debt	N/A	$2.9M	N/A	N/A	N/A	N/A
Total Equity	$70.1M-11.3%	$79.1M+14479.5%	$542K-28.9%	$763K-79.8%	$3.8M-56.6%	$8.7M
Retained Earnings	-$80.6M-106.3%	-$39.0M-17.4%	-$33.2M-68.6%	-$19.7M-21.4%	-$16.2M-48.6%	-$10.9M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$80.7M-4.2%	$84.2M-19.7%	$104.8M+0.5%	$104.3M+23.9%	$84.2M-19.7%	$104.9M+11.2%	$94.3M+534.8%	$14.8M
Current Assets	$4.8M-39.7%	$7.9M+457.1%	$1.4M+65.9%	$857K-89.1%	$7.8M+24.1%	$6.3M-13.1%	$7.3M-40.3%	$12.1M
Cash & Equivalents	$3.5M-46.8%	$6.7M+1773.0%	$356K+2211.0%	$15K-99.2%	$2.0M+565.3%	$308K-46.8%	$579K-92.5%	$7.7M
Inventory	$211K-1.2%	$213K-9.0%	$235K	N/A	N/A	N/A	$8K+22.4%	$6K
Accounts Receivable	$723K-1.2%	$731K+23.9%	$590K	N/A	$4K-66.4%	$11K+6.5%	$10K-20.3%	$13K
Goodwill	N/A	N/A	$21.4M0.0%	$21.4M0.0%	$21.4M0.0%	$21.4M+172.3%	$7.8M	N/A
Total Liabilities	$13.8M-1.5%	$14.1M-36.6%	$22.2M-16.2%	$26.4M+776.6%	$3.0M-88.3%	$25.8M+182.5%	$9.1M+198.0%	$3.1M
Current Liabilities	$2.8M+2.5%	$2.7M-62.8%	$7.4M-4.4%	$7.7M	N/A	$7.9M+46.1%	$5.4M+86.5%	$2.9M
Long-Term Debt	N/A	N/A	$2.0M-44.1%	$3.6M+15.7%	$3.1M+6.7%	$2.9M	N/A	N/A
Total Equity	$66.8M-4.7%	$70.1M-15.2%	$82.7M+6.2%	$77.9M-4.1%	$81.2M+2.6%	$79.1M-7.1%	$85.1M+622.3%	$11.8M
Retained Earnings	-$84.0M-4.2%	-$80.6M-53.6%	-$52.4M-7.4%	-$48.8M-16.0%	-$42.1M-7.8%	-$39.0M-22.5%	-$31.9M-20.3%	-$26.5M

SCNX Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$13.4M+6.2%	-$14.3M-541.1%	-$2.2M-45.8%	-$1.5M+40.5%	-$2.6M-15.9%	-$2.2M
Capital Expenditures	N/A	$12K	N/A	N/A	$23K-39.8%	$38K
Free Cash Flow	N/A	-$14.3M	N/A	N/A	-$2.6M-14.9%	-$2.3M
Investing Cash Flow	N/A	$27.6M+10093.1%	-$276K+35.6%	-$428K-1793.5%	-$23K+39.8%	-$38K
Financing Cash Flow	$19.7M+252.0%	-$13.0M-1023.0%	$1.4M+4098.6%	-$35K+83.1%	-$208K-103.9%	$5.3M
Dividends Paid	N/A	$14.9M	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$2.9M+43.6%	-$5.2M-61.0%	-$3.2M-58.0%	-$2.0M+31.2%	-$3.0M-1.6%	-$2.9M+46.0%	-$5.4M-227.6%	$4.2M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	$0	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	-$2.9M	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$121K+15730.0%	-$774
Financing Cash Flow	-$200K-101.7%	$11.5M+223.1%	$3.6M	$0-100.0%	$4.7M+68.4%	$2.8M+248.9%	-$1.9M	$0
Dividends Paid	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$2.2M	$0
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

SCNX Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	76.8%+72.4pp	4.4%+0.8pp	3.6%-50.2pp	53.8%+5.9pp	48.0%+14.7pp	33.3%
Operating Margin	-9867.9%+890.8pp	-10758.7%-10436.3pp	-322.4%-293.9pp	-28.4%+25.1pp	-53.5%-38.9pp	-14.6%
Net Margin	-9618.0%-16252.7pp	6634.7%+7943.0pp	-1308.3%-1274.5pp	-33.9%+19.9pp	-53.8%-38.9pp	-14.8%
Return on Equity	-59.2%-70.7pp	11.5%+3301.5pp	-3290.0%-2835.1pp	-455.0%-314.0pp	-141.0%-111.8pp	-29.2%
Return on Assets	-49.3%-58.0pp	8.6%+151.0pp	-142.4%-48.8pp	-93.6%-1.4pp	-92.2%-66.3pp	-25.9%
Current Ratio	2.89+2.1	0.80+0.6	0.24-0.7	0.97-3.7	4.72-6.2	10.95
Debt-to-Equity	0.20+0.2	0.04-22.1	22.11+17.7	4.41+3.9	0.53+0.4	0.13
FCF Margin	N/A	-10448.6%	N/A	N/A	-26.2%-13.0pp	-13.2%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	95.6%	N/A	97.4%	N/A	6.6%	N/A	6.0%+9.8pp	-3.8%
Operating Margin	-6230.8%	N/A	-739.1%	N/A	-34814.9%	N/A	-5392.8%+2606.0pp	-7998.8%
Net Margin	-6040.4%	N/A	-611.4%	N/A	-29869.3%	N/A	-4908.3%+4899.2pp	-9807.5%
Return on Equity	-5.1%	N/A	-4.4%+4.3pp	-8.6%-4.9pp	-3.8%	N/A	-3.7%+11.8pp	-15.6%
Return on Assets	-4.2%	N/A	-3.4%+3.0pp	-6.4%-2.8pp	-3.6%	N/A	-3.4%+9.0pp	-12.3%
Current Ratio	1.70-1.2	2.89+2.7	0.19+0.1	0.11	N/A	0.80-0.5	1.34-2.8	4.18
Debt-to-Equity	0.210.0	0.20+0.2	0.02-0.0	0.050.0	0.040.0	0.04-0.1	0.11-0.2	0.26
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Cellyan Biotechnology Co Ltd HKPD

$12.3M

Sunlink Hlth SSY

$6.8M

Petmed Express Inc PETS

$47.1M

Wellgistics Health Inc. WGRX

$9.3M

High Tide HITI

$219.7M

Frequently Asked Questions

What is Scienture Holdings, Inc's annual revenue?

Scienture Holdings, Inc (SCNX) reported $432K in total revenue for fiscal year 2025. This represents a 215.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Scienture Holdings, Inc's revenue growing?

Scienture Holdings, Inc (SCNX) revenue grew by 215.9% year-over-year, from $137K to $432K in fiscal year 2025.

Is Scienture Holdings, Inc profitable?

No, Scienture Holdings, Inc (SCNX) reported a net income of -$41.5M in fiscal year 2025, with a net profit margin of -9618.0%.

What is Scienture Holdings, Inc's EBITDA?

Scienture Holdings, Inc (SCNX) had EBITDA of -$42.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Scienture Holdings, Inc's gross margin?

Scienture Holdings, Inc (SCNX) had a gross margin of 76.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Scienture Holdings, Inc's operating margin?

Scienture Holdings, Inc (SCNX) had an operating margin of -9867.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Scienture Holdings, Inc's net profit margin?

Scienture Holdings, Inc (SCNX) had a net profit margin of -9618.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Scienture Holdings, Inc's return on equity (ROE)?

Scienture Holdings, Inc (SCNX) has a return on equity of -59.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Scienture Holdings, Inc's operating cash flow?

Scienture Holdings, Inc (SCNX) generated -$13.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Scienture Holdings, Inc's total assets?

Scienture Holdings, Inc (SCNX) had $84.2M in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Scienture Holdings, Inc spend on research and development?

Scienture Holdings, Inc (SCNX) invested $2.0M in research and development during fiscal year 2025.

How many shares does Scienture Holdings, Inc have outstanding?

Scienture Holdings, Inc (SCNX) had 41M shares outstanding as of fiscal year 2025.

What is Scienture Holdings, Inc's current ratio?

Scienture Holdings, Inc (SCNX) had a current ratio of 2.89 as of fiscal year 2025, which is generally considered healthy.

What is Scienture Holdings, Inc's debt-to-equity ratio?

Scienture Holdings, Inc (SCNX) had a debt-to-equity ratio of 0.20 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Scienture Holdings, Inc's return on assets (ROA)?

Scienture Holdings, Inc (SCNX) had a return on assets of -49.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Scienture Holdings, Inc's cash runway?

Based on fiscal year 2025 data, Scienture Holdings, Inc (SCNX) had $6.7M in cash against an annual operating cash burn of $13.4M. This gives an estimated cash runway of approximately 6 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Scienture Holdings, Inc's Piotroski F-Score?

Scienture Holdings, Inc (SCNX) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Scienture Holdings, Inc's earnings high quality?

Scienture Holdings, Inc (SCNX) has an earnings quality ratio of 0.32x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Scienture Holdings, Inc cover its interest payments?

Scienture Holdings, Inc (SCNX) has an interest coverage ratio of -10.4x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Scienture Holdings, Inc?

Scienture Holdings, Inc (SCNX) scores 26 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.